Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
43,386,194
-
Shares change
-
+5,903,887
-
Total reported value, excl. options
-
$3,146,822,308
-
Value change
-
+$421,342,946
-
Number of buys
-
93
-
Number of sells
-
-22
-
Price
-
$72.52
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q4 2020
129 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share as of Q4 2020.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,386,194 shares
of 75,607,738 outstanding shares and own 57% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,406,307 shares), Bain Capital Life Sciences Investors, LLC (7,281,307 shares), PERCEPTIVE ADVISORS LLC (4,177,721 shares), FMR LLC (3,378,020 shares), BlackRock Inc. (2,246,143 shares), BOXER CAPITAL, LLC (2,075,905 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,442,970 shares), ArrowMark Colorado Holdings LLC (1,288,300 shares), VANGUARD GROUP INC (1,271,145 shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (1,155,309 shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.